Bio Green Med Solution (BGMS) EBT Growth (5y) (2015 - 2026)
Analysis
Bio Green Med Solution (BGMS) EBT Growth (5y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.60 Bn | 133.75 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.38 Bn | 78.38 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.83 Bn | 59.64 Bn | 1.37 Bn |
| 4 | Moderna | 57.69 Bn | 52.56 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.46 Bn | 44.46 Bn | - |
| 6 | BeOne Medicines | 40.31 Bn | 35.21 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.12 Bn | 27.28 Bn | - |
| 9 | Insmed | 27.40 Bn | 26.23 Bn | 358.27 Mn |
| 10 | Bio Green Med Solution | 4.95 Mn | 1.16 Mn | 79,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.11% |
| Mar 31, 2026 | 47.44% |
| Dec 31, 2025 | 28.23% |
| Sep 30, 2025 | 17.19% |
| Jun 30, 2025 | 12.63% |
| Mar 31, 2025 | -22.74% |
| Dec 31, 2024 | 7.21% |
| Sep 30, 2024 | 0.06% |
| Jun 30, 2024 | -11.91% |
| Mar 31, 2024 | -15.30% |
| Dec 31, 2023 | -18.96% |
| Sep 30, 2023 | -23.11% |
| Jun 30, 2023 | -20.71% |
| Mar 31, 2023 | -36.00% |
| Dec 31, 2022 | -34.16% |
| Sep 30, 2022 | -24.10% |
| Jun 30, 2022 | -17.76% |
| Mar 31, 2022 | -23.03% |
| Dec 31, 2021 | -13.93% |
| Sep 30, 2021 | -10.85% |